Biktarvy, formally known as bictegravir sulfate, represents a powerful single-tablet regimen for managing HIV infection. This formula integrates three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It works by preventing the HIV's ability to multiply within the body, considerably decreasing the viral load. For many i